Literature DB >> 23887095

Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction.

Nosratola D Vaziri1, Jun Yuan, Sohrab Nazertehrani, Zhenmin Ni, Shuman Liu.   

Abstract

BACKGROUND: Integrity of the tight junction (TJ) which seals the gap between the epithelial cells of the gastrointestinal tract is critical in preventing the entry of the microbial toxins, antigens, and other harmful products in the subepithelial tissues and the internal milieu. By enabling the absorption of these products, impairment of the intestinal epithelial barrier leads to local and systemic inflammation. We have recently found depletion of the key protein constituents of colonic epithelial TJ in animals with chronic kidney disease (CKD). Postmortem studies have revealed the presence of inflammation throughout the gastrointestinal tract in uremic humans. This observation suggests that uremia may cause disruption of the epithelial barrier in all segments of the gastrointestinal tract including the stomach, jejunum, and ileum. The present study was undertaken to explore this possibility.
METHODS: Sprague-Dawley rats were randomized to CKD or control groups. The CKD group was subjected to 5/6 nephrectomy while the control group underwent a sham operation. The animals were observed for 10 weeks at which time they were euthanized and their stomachs, jejunums, and ileums were removed and processed for measurement of TJ proteins.
RESULTS: The CKD rats showed marked azotemia, systemic oxidative stress, and marked depletion of the key protein constituents of the epithelial TJ (claudin-1, occludin, and ZO1) in the stomach, jejunum, and ileum.
CONCLUSIONS: The present study extends the earlier finding of uremia-induced disruption of colonic epithelial TJ by documenting the involvement of the stomach, jejunum, and ileum as well.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23887095     DOI: 10.1159/000353764

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  56 in total

1.  Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.

Authors:  Wei Ling Lau; Shu-Man Liu; Sogol Pahlevan; Jun Yuan; Mahyar Khazaeli; Zhenmin Ni; Jefferson Y Chan; Nosratola D Vaziri
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

2.  Kidney Disease Progression Does Not Decrease Intestinal Phosphorus Absorption in a Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.

Authors:  Colby J Vorland; Annabel Biruete; Pamela J Lachcik; Shruthi Srinivasan; Neal X Chen; Sharon M Moe; Kathleen M Hill Gallant
Journal:  J Bone Miner Res       Date:  2019-11-15       Impact factor: 6.741

Review 3.  Hemodialysis-induced cardiovascular disease.

Authors:  Shadi Ahmadmehrabi; W H Wilson Tang
Journal:  Semin Dial       Date:  2018-04-06       Impact factor: 3.455

4.  Gut microbial translocation in the pathogenesis of systemic inflammation in patients with end-stage renal disease.

Authors:  Nosratola D Vaziri
Journal:  Dig Dis Sci       Date:  2014-09       Impact factor: 3.199

Review 5.  Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.

Authors:  Wei Pan; Yongbo Kang
Journal:  Int Urol Nephrol       Date:  2017-08-28       Impact factor: 2.370

6.  A Renal Clinician's Guide to the Gut Microbiota.

Authors:  Matthew Snelson; Annabel Biruete; Catherine McFarlane; Katrina Campbell
Journal:  J Ren Nutr       Date:  2020-01-09       Impact factor: 3.655

Review 7.  The Gut as a Source of Inflammation in Chronic Kidney Disease.

Authors:  Wei Ling Lau; Kamyar Kalantar-Zadeh; Nosratola D Vaziri
Journal:  Nephron       Date:  2015-05-09       Impact factor: 2.847

8.  Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.

Authors:  Eikan Mishima; Shinji Fukuda; Hisato Shima; Akiyoshi Hirayama; Yasutoshi Akiyama; Yoichi Takeuchi; Noriko N Fukuda; Takehiro Suzuki; Chitose Suzuki; Akinori Yuri; Koichi Kikuchi; Yoshihisa Tomioka; Sadayoshi Ito; Tomoyoshi Soga; Takaaki Abe
Journal:  J Am Soc Nephrol       Date:  2014-12-18       Impact factor: 10.121

Review 9.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

10.  Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.

Authors:  Jason R Stubbs; John A House; A Jacob Ocque; Shiqin Zhang; Cassandra Johnson; Cassandra Kimber; Kyle Schmidt; Aditi Gupta; James B Wetmore; Thomas D Nolin; John A Spertus; Alan S Yu
Journal:  J Am Soc Nephrol       Date:  2015-07-30       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.